
At the Vitrolife Group, we work every day to unlock the full potential of science and technology to reduce the barriers towards building a family. Together we help our customers and their patients to fulfill the dream of having a baby.
Behind every successful global healthcare operation, there is a dedicated Customer Service team ensuring that every interaction is seamless, supportive and handled with care.
Customer Support & Experience
• Be the first point of contact for clinics and private patients via phone and email.
• Provide clear information about genetic testing services and guide customers.
• Track, manage and resolve customer inquiries proactively.
Operational Coordination
• Collaborate closely with Laboratory, Diagnostics, and Genetic Counseling teams.
• Manage customer data in Salesforce CRM and Navision.
• Support payment collections, kit requests, and account management.
Process Quality & Collaboration
• Ensure accurate, up-to-date customer information.
• Contribute to improved service processes.
· Bachelor’s degree or equivalent.
· Experience: 3+ years in customer service, ideally in healthcare.
· Technical skills: Salesforce, Navision, Microsoft Office.
· Languages: Fluent in French and English; intermediate Spanish is a plus.
· Strong communication, problem-solving and collaboration skills.
Because here, customer care meets purpose You will join a global healthcare company supporting patients in building families, guided by quality, integrity, innovation and collaboration.
• Opportunity to work in a leading global organization in healthcare and genetic services.
• International exposure and participation in global projects.
• Supportive and collaborative work environment.
• Remote work 1 day per week possible.
• Medical insurance.
• Flexible compensation options.
• Discounts on our platform and gym memberships.
• Free coffee at the workplace.
• Job stability in a growing and innovative company.
*The interview will be conducted in English
Vitrolife Group is a global provider of medical devices and genetic services. Based on science and advanced research capabilities, we develop services and products for personalised genetic information and medical device products. We support our customers by improving their clinical practice for the patient's outcome of a fertility treatment.
We are currently approximately 1 100 colleagues worldwide, with headquarters in Gothenburg, Sweden. Vitrolife Group's products and services are available in more than 110 countries through our own presence in 30 countries and a network of distributors. Vitrolife Group is a sustainable market leader and aims to be the preferred partner for IVF-clinics by providing superior products and services with the vision of fulfilling the dream of having a baby. The Vitrolife share is listed on Nasdaq Stockholm.

The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry.
In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality.
Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading valued solution provider in reproductive health and to support customers with successful treatment outcomes.